93
Views
3
CrossRef citations to date
0
Altmetric
CASE REPORT

Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin

, , , , , & show all
Pages 377-380 | Received 10 Jul 2006, Accepted 21 Jul 2006, Published online: 12 Jul 2009

References

  • Antman K., Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027–38
  • Geramineja P., Memar O., Aronson I., Raddy P. L., Hengge U., Tyring S. K. Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol 2002; 47: 641–55
  • Babál O., Péct J. Kaposi's sarcoma – still an enigma. J Eur Acad Dermatol Venereol 2003; 17: 377–80
  • Noy A. Update in Kaposi sarcoma. Curr Opin Oncol 2003; 15: 379–81
  • Dezube B. J. New therapies for the treatment of AIDS‐related Kaposis sarcoma. Curr Opin Oncol 2000; 12: 445–9
  • Gascon P., Swarts R. A. Kaposi's sarcoma. New treatment modalities. Dermatol Clin 2000; 18: 169–75
  • Dezube B. J. Acquired immunodeficiency syndrome‐related Kaposis's sarcoma: Clinical features, staging and treatment. Semin Oncol 2000; 27: 424–30
  • Sharpe M., Easthope S. E., Keating G. M., Lamb H. M. Polyethylen glycol‐liposomal doxorubicin. Drugs 2002; 62: 2089–126
  • Von Roenn J. H. Clinical presentations and standard therapy of AIDS‐associated Kaposi's sarcoma. Hematol Oncol Clin North Am 2003; 17: 747–62
  • Hengge U. R., Esser S., Rudel H. P., Goos M. Long‐term chemotherapy of HIV‐associated Kaposi's sarcoma with liposomal doxorubicin. Eur J Cancer 2001; 37: 878–83
  • Steward S., Jablonowski H., Goebel F. D., Arasteh K., Spittl M., Rios A., et al. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS‐related Kaposi's sarcoma. J Clin Oncol 1998; 16: 683–91
  • Allen T. M., Martin F. J. Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 2004; 31((suppl 13))5–15
  • Vail D. M., Amantea M. A., Colbern G. T., Martin F. J., Hilger R. A., Working P. K. Pegylated doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin Oncol 2004; 31((suppl 13))16–35
  • Krown S. E., Northfelt D. W., Osoba D., Stewart S. Use of liposomal anthracyclines in Kaposi's sarcoma. Semin Oncol 2004; 31((suppl 13))36–52
  • Gottlieb J. J., Washenik K., Chachoua A., Friedman‐Kien A. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin. Lancet 1997; 350: 1363–4
  • Kreuter A., Rasokat H., Klouche M., Esser S., Bader A., Gambichler T., et al. Liposomal pegylated doxorubicin versus low‐dose recombinant interferon alfa‐2a in the treatment of advanced classic Kaposi's sarcoma; Retrospective analysis of three German centers. Cancer Invest 2005; 23: 653–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.